These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

487 related articles for article (PubMed ID: 18383379)

  • 1. Genetic association of vasoactive intestinal peptide receptor with rheumatoid arthritis: altered expression and signal in immune cells.
    Delgado M; Robledo G; Rueda B; Varela N; O'Valle F; Hernandez-Cortes P; Caro M; Orozco G; Gonzalez-Rey E; Martin J
    Arthritis Rheum; 2008 Apr; 58(4):1010-9. PubMed ID: 18383379
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differential expression of vasoactive intestinal peptide and its functional receptors in human osteoarthritic and rheumatoid synovial fibroblasts.
    Juarranz Y; Gutiérrez-Cañas I; Santiago B; Carrión M; Pablos JL; Gomariz RP
    Arthritis Rheum; 2008 Apr; 58(4):1086-95. PubMed ID: 18383383
    [TBL] [Abstract][Full Text] [Related]  

  • 3. VIP attenuation of the severity of experimental pancreatitis is due to VPAC1 receptor-mediated inhibition of cytokine production.
    Kojima M; Ito T; Oono T; Hisano T; Igarashi H; Arita Y; Kawabe K; Coy DH; Jensen RT; Nawata H
    Pancreas; 2005 Jan; 30(1):62-70. PubMed ID: 15632701
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Altered expression of vasoactive intestinal peptide receptors in T lymphocytes and aberrant Th1 immunity in multiple sclerosis.
    Sun W; Hong J; Zang YC; Liu X; Zhang JZ
    Int Immunol; 2006 Dec; 18(12):1691-700. PubMed ID: 17077178
    [TBL] [Abstract][Full Text] [Related]  

  • 5. VPAC1 (vasoactive intestinal peptide (VIP) receptor type 1) G protein-coupled receptor mediation of VIP enhancement of murine experimental colitis.
    Yadav M; Huang MC; Goetzl EJ
    Cell Immunol; 2011; 267(2):124-32. PubMed ID: 21295288
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evidence for neural regulation of inflammatory synovial cell functions by secreting calcitonin gene-related peptide and vasoactive intestinal peptide in patients with rheumatoid arthritis.
    Takeba Y; Suzuki N; Kaneko A; Asai T; Sakane T
    Arthritis Rheum; 1999 Nov; 42(11):2418-29. PubMed ID: 10555038
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vasoactive intestinal peptide (VIP) receptor expression in monocyte-derived macrophages from COPD patients.
    Burian B; Storka A; Marzluf BA; Yen YC; Lambers C; Robibaro B; Vonbank K; Mosgoeller W; Petkov V
    Peptides; 2010 Apr; 31(4):603-8. PubMed ID: 20026142
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Down-regulation of vasoactive intestinal peptide and altered expression of its receptors in rat diabetic cardiomyopathy.
    Dvoráková MC; Pfeil U; Kuncová J; Svíglerová J; Galvis G; Krasteva G; König P; Grau V; Slavíková J; Kummer W
    Cell Tissue Res; 2006 Mar; 323(3):383-93. PubMed ID: 16344947
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vivo delivery of lentiviral vectors expressing vasoactive intestinal peptide complementary DNA as gene therapy for collagen-induced arthritis.
    Delgado M; Toscano MG; Benabdellah K; Cobo M; O'Valle F; Gonzalez-Rey E; Martín F
    Arthritis Rheum; 2008 Apr; 58(4):1026-37. PubMed ID: 18383372
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical Relevance of VPAC1 Receptor Expression in Early Arthritis: Association with IL-6 and Disease Activity.
    Seoane IV; Ortiz AM; Piris L; Lamana A; Juarranz Y; García-Vicuña R; González-Álvaro I; Gomariz RP; Martínez C
    PLoS One; 2016; 11(2):e0149141. PubMed ID: 26881970
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vasoactive intestinal peptide induces CD4+,CD25+ T regulatory cells with therapeutic effect in collagen-induced arthritis.
    Gonzalez-Rey E; Fernandez-Martin A; Chorny A; Delgado M
    Arthritis Rheum; 2006 Mar; 54(3):864-76. PubMed ID: 16508968
    [TBL] [Abstract][Full Text] [Related]  

  • 12. VIP enhances synaptic transmission to hippocampal CA1 pyramidal cells through activation of both VPAC1 and VPAC2 receptors.
    Cunha-Reis D; Ribeiro JA; Sebastião AM
    Brain Res; 2005 Jul; 1049(1):52-60. PubMed ID: 15935995
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A lymphocyte-generated fragment of vasoactive intestinal peptide with VPAC1 agonist activity and VPAC2 antagonist effects.
    Summers MA; O'Dorisio MS; Cox MO; Lara-Marquez M; Goetzl EJ
    J Pharmacol Exp Ther; 2003 Aug; 306(2):638-45. PubMed ID: 12750439
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression localisation and functional activity of pituitary adenylate cyclase-activating polypeptide, vasoactive intestinal polypeptide and their receptors in mouse ovary.
    Barberi M; Muciaccia B; Morelli MB; Stefanini M; Cecconi S; Canipari R
    Reproduction; 2007 Aug; 134(2):281-92. PubMed ID: 17660238
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vasoactive intestinal peptide inhibits toll-like receptor 3-induced nitric oxide production in Schwann cells and subsequent sensory neuronal cell death in vitro.
    Lee H; Park K; Kim JS; Lee SJ
    J Neurosci Res; 2009 Jan; 87(1):171-8. PubMed ID: 18683246
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anti-hyperglycemic, antioxidant and anti-inflammatory effects of VIP and a VPAC1 agonist on streptozotocin-induced diabetic mice.
    Yu R; Zhang H; Huang L; Liu X; Chen J
    Peptides; 2011 Feb; 32(2):216-22. PubMed ID: 21129425
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The neurotransmitter VIP expands the pool of symmetrically dividing postnatal dentate gyrus precursors via VPAC2 receptors or directs them toward a neuronal fate via VPAC1 receptors.
    Zaben M; Sheward WJ; Shtaya A; Abbosh C; Harmar AJ; Pringle AK; Gray WP
    Stem Cells; 2009 Oct; 27(10):2539-51. PubMed ID: 19650041
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mechanisms of vasoactive intestinal peptide-elicited coronary vasodilation in the isolated perfused rat heart.
    Sawmiller DR; Ashtari M; Urueta H; Leschinsky M; Henning RJ
    Neuropeptides; 2006 Oct; 40(5):349-55. PubMed ID: 17030371
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association of arthritis with a gene complex encoding C-type lectin-like receptors.
    Lorentzen JC; Flornes L; Eklöw C; Bäckdahl L; Ribbhammar U; Guo JP; Smolnikova M; Dissen E; Seddighzadeh M; Brookes AJ; Alfredsson L; Klareskog L; Padyukov L; Fossum S
    Arthritis Rheum; 2007 Aug; 56(8):2620-32. PubMed ID: 17665455
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serine 447 in the carboxyl tail of human VPAC1 receptor is crucial for agonist-induced desensitization but not internalization of the receptor.
    Marie JC; Rouyer-Fessard C; Couvineau A; Nicole P; Devaud H; El Benna J; Laburthe M
    Mol Pharmacol; 2003 Dec; 64(6):1565-74. PubMed ID: 14645688
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.